Children's asthma and the third world: An approach

Journal of Investigational Allergology and Clinical Immunology

Volumn 16, Issue 1, 2006, Pages 11-18

  Capriles, E ^a   Do Campo, A ^b   Verde, O ^c   Pluchino, S ^d   Capriles Hulett, A ^b,e  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Hospital San Juan de Dios Caracas   (Venezuela)

^c Lab de Alimentos de Origen Animal   (Venezuela)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^e CCS 211 ^*  (United States)

Author keywords

Approach; Asthma; Children; Cost effectiveness; Third world

Indexed keywords

BUDESONIDE; INFLAMMIDE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; QUALITY OF LIFE; SYMPTOMATOLOGY; TREATMENT OUTCOME; VENEZUELA;

ADOLESCENT; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BUDESONIDE; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFANT; INFANT, NEWBORN; PEAK EXPIRATORY FLOW RATE; PILOT PROJECTS; SKIN TESTS; TREATMENT OUTCOME; VENEZUELA;

EID: 33646514833     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Worldwide variations in the prevalence of asthma symptoms: The International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J. 1998; 12:315-35.
2. Vichyanond, P.; Weinberg, E.; Sole, D. Childhood asthma in developing countries. In Naspitz, C.; Szefler, S.; Tinkelman, D.; Warner, J. Martin Dunitz (Ed), Textbook of Pediatric Asthma: an International Perspective. 2001. pp. 377-390.
3. Cabral, A.L.; Gavalho, W.A.; Chinen, M.; Barbiroto, R.M.; Boueri, F.M.; Martins, M.A. Are International Asthma Guidelines effective for low- income Brazilian children with asthma? Eur Respir J. 1998; 12: 35- 40.
4. Benguigui, Y.; Alves de Cunha. El control del niño con asma dentro del contexto AIEPI. In Malka, S y Malka, J. (Ed), Progresos en Alergia e Inmunología Clínica: Avances Recientes, editores 2002, 6-14.
5. th International Congress of Pediatrics, Cancun, Mexico, 2004.
6. Blaiss, M. Pediatric asthma disease management programs. Do they work? Guest Editorial. Ann. Allergy Asthma Immunol. 2003; 90: 282-283.
7. Perera, B.J.C. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. Arch. Dis. Child. 1995; 72: 312-316.
8. Busse, W.; Lenfant, C.; Lemanske, R. (Editorial). J. Allergy Clin. Immunol. 2002; 110 (5): 703-705.
9. Spector, S. Non compliance with asthma therapy - Are there solutions? J. Asthma. 2002; 37:381-388.
10. Bender, B. Strategies that improve adherence to asthma therapy. Contemporary Pediatrics. 2003; (Suppl April): 4:11.
11. Bender, B., Milgrom, H., Apter, A. Adherence intervention research: what have we learned and what do we do next. J Allergy Clin Immunol. 2003; 112:489-494.
12. ASTHMA. Archivos Venezolanos de Puericultura y Pediatria. 2003; 66 (Suppl 1).
13. Centro de Información y Documentación Empresarial sobre Iberoamerica. (CIDEIBER), [Available from: www.cideiber.com/infopaises/ Venezuela. Accessed Jan 2004].
14. Jiménez de Landaeta, M. Asma bronquial y situación socioeconómica en Venezuela. Rev. Soc. Venez. Alergia Asma e Immunol. 1999; 1(1), 5-10.
15. Drug sales in Latin America. Available from www.IMShealth.com, unit sales R3 Venezuela. Accessed Jan 2004.
16. Capriles-Hulett, A.; Carvallo,C.;Sanchez,A; Alfonzo,I.; Kondracki,E. Revision sobre el estado del asma infantil en Venezuela y una propuesta para su manejo. Revista de la Sociedad Venezolana de Alergia, Asma e Inmunologia. 2004; 6 (1):25-35.
17. Capriles, E.; Malka, J.; Sanchez-Borges, M. Farmacoeconomía de las enfermedades alérgicas en Venezuela. Revista de la Sociedad Venezolana de Alergia, Asma e Inmunología. 2001; 2(1): 5-15.
18. Aldrey, O.; De Stefano, M.; Capriles Hulett, A. Prevalencia del asma infantil en Venezuela, ISAAC Venezuela 2003. Rev Venezolana de Alergia, Asma e Inmunologia. 2003; 5 (2):33-42.
19. Sánchez-Borges, M.; Capriles-Hulett, A.; Caballero-Fonseca, F.; Fernandez-Caldas, E.; et al. Mite and cockroach sensitization in allergic patients from Caracas, Venezuela. Ann. Allergy Asthma Immunol. 2003; 9(6): 664-668.
20. Fischer, G.B.,Moreira Camargos P.A.,Mocelin, H.T. The Burden of asthma in children: Latin American perspective. Paediatric Respiratory Reviews 2005; 6: 8-13
21. Smith, M.J.; Rascati, K.L.; Johnsrud, M. Cost and utilization patterns associated with persistent asthma: a comparison of Texas Medicaid patients with and without continuous inhaled corticosteroid treatment. J Managed Care Pharm. 2001; 7: 452-9.
22. Adams, R.J.; Fuhlbrigge, A.; Finkelstein, J.A.; Lozano, P.; Livingstone, J.M.; Weiss, K.B.; Weiss, S.T. Impact of inhaled anti-inflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics. 2001; 107: 706-11.
23. Suissa, S.; Ernst, P.; Kezouh, A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax. 2002; 57: 880-884.
24. Schatz, M.; Francis Cook, E.; Nakahiro, R.; Pettiti, D. Inhaled corticosteroids and allergy specialty care can reduce emergency hospital use for asthma. J Allergy Clin. Immunol. 2003; 11: 503-508.
25. Suissa, S.; Ernst, P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J. Allergy Clin Immunol. 2001; 107: 937-944.
26. Suissa, S.; Ernst, P.; Benayoun, S.; Baltzan, M.; Cai, B. Low dose inhaled corticosteroid and the prevention of death from asthma. N. Engl. J. Med. 2000; 343(5), 332-336
27. Kamps, A.W.A.; Roorda, R.J.; Brand, P.L.P. Peak flow diaries in childhood asthma are unreliable. Thorax. 2001; 56:180-182.
28. Barnes, P.J.; Pedersen. S.; Busse, W.W. Efficacy and safety of inhaled corticosteroids. New Developments. Am. J. Resp. Crit. Care Med. 1998; 157 (3 part 2): S1-S53.
29. O'Byrne, P.; Pedersen, S. Measuring efficacy and safety of different inhaled corticosteroid preparations. J Allergy Clin. Immunol. 1998; 102: 879-886.
30. Miller-Larsson, A.; Mattsson, H.; Hjertberg, E.; Dahlback, M.; Tunek, A.; Brattsand, R. Reversible fatty acid conjugation of budesonide: a novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos. 1998; 26:623-630.
31. Pedersen, S.; Hansen, O.R. Budesonide treatment of moderate and severe asthma in children: a dose response study. J Allergy Clin. Inmunol. 1995; 15: 29-33.
32. Childhood Asthma Management Program (CAMP) Research Group. Long term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000; 343 (15): 1054-1063.
33. Agertoft, L.; Pedersen, S. Effects of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med. 2000; 343:1064-1069.
34. Nelson, H. Guest Editorial. Corticosteroid dosing and asthma control. Ann. Allergy Asthma Immunol 2001. 86; 599-602.
35. Banov, CH.; Howland, W.C.; Lumry, W.R. Once daily budesonide via turbohaler improves symptoms in adults with persistent asthma. Ann Allergy Asthma Immunol. 2001; 87: 627-632.
36. Shapiro, G.G.; Mendelson, L.M.; Pearlman, D.S. Once daily budesonide inhalation powder (Pulmicort turbohaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Ann Allergy Asthma Immunol. 2001; 87: 633-640.
37. McFadden, E.R.; Casale, T.B.; Edwards, T.B.; Kemp, J.; Metzger, J.; Nelson, H.S.; Storms, W.W.; Neidl, M.; et al. Administration of budesonide once daily by means of turbohaler to subjects with stable asthma. J. Allergy Clin Immunol. 1999; 104: 46-52.
38. Jones, A.H.; Langdon, C.G.; Lee, P.S.; et al Pulmicort turbohaler once daily as initial prophylactic therapy for asthma. Respir. Med. 1994; 88: 293-299.
39. Weiner, P.; Weiner, M.; Azgad, Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax. 1995; 50: 1270-1273.
40. Jonason, G.; Carlsen, K.H.; Blomqvist, P. Clinical efficacy of low dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. Eur. Respir. J. 1998; 12: 1099-1104.
41. Campbell, L.M.; Bodalia, B.; Gogbashian, C.A.; Gunn, S.D.; Humpreys, P.J.; Powell, J.P. Once daily budesonide 400μg daily is as effective as 200μg twice daily in controlling childhood asthma .PETITE Research Group. Int J Clin Pract. 1998; 52: 213-219.
42. Moller, C.; Stromberg, L.; Oldaeus, G.; et al Efficacy of once daily budesonide (Turbohaler) in children with stable asthma. Pediatr. Pulmonol. 1999; 28: 337-343.
43. Baker, J.W.; Mellon, M.; Wald, J.; Welch, M.; Cruz-Rivera, M.; Fitzpatrick, S.; Smith, J.A. Multiple-dosing, placebo controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics. 1999; 103: 414-421.
44. Mellon, M.; Leflein, J.; Walton-Bowen, K.; et al. Comparable efficacy of administration with facemask, or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am. J Respir Crit Care Med. 2000; 162:593-598.
45. Kemp, J.P.; Skoner, D.P.; Szefler, S.J.; Walton-Bowen, K.; Cruz-Rivera, M.; Smith JA. Once daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. Ann Allergy Asthma Immunol. 1999; 83:231-9.
46. Dubus, J.C.; Anhoj, J. A review of once daily delivery of antiasthmatic drugs in children. Ped. Allergy Immunol. 2003; 14: 4-9.
47. Goldberg, S.; Einot, T.; Algur, N.; Schwartz, S.; Greenberg, A.C.; Picard, E.; Virgilis, D.; Kerem, E. Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer. Ann. Allergy Asthma Immunol. 2003; 89: 566-571.
48. Heuck, C.; Wolthers, O.D.; Kollerup, G.; Hansen, M.; Teiner, B. Adverse effect of inhaled budesonide (800μg) on growth and collagen turnover in children with asthma: A double blind comparison of once daily vs. twice-daily administration. J. Pediatr. 1998; 133: 608-612.
49. Selroos, D., Edsbacker,S. and Hultquist, C. Once daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.J of Asthma. 2004; 4,8: 771-790.
50. República Bolivariana de Venezuela. In Gaceta Oficial Número 3768l. 23 Mayo, 2003. Decreto 2387 del 29 de Abril del 2003. Salario Urbano: Bs. 209.088.
51. Perera, B.J.C. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country: an epilogue. Arch Dis Child. 1995,73:482.
52. Kamps, A.W.A., Roorda,R.J., Brabd, P.L.L. Peak flow dairies in childhood asthma are unreliable. Thorax. 2001; 56:180-182.
53. Reeder, K.P.; Dolce, J.J.; Duke, L.; Raizynski, J.M.; Bailey, W.C. Peak expiratory flow rate meters: are they monitoring tools or training devices? J Asthma. 1999; 27: 219-227.
54. Lorrie Yoos, H.; Kitzman, H.; Mc Mullen, A.; Henderson, C.; Sidora, K. Symptom monitoring in childhood asthma: a randomized clinical trial comparing peak expiratory flow rate with symptom monitoring. Ann Allergy Asthma Immunol. 2002; 88: 283-291.
55. Sly, P.D. Peak expiratory flow monitoring in pediatric asthma: is there a role. J Asthma. 1996; 33: 277-87.
56. Sly, P.D. Relationship between change in PEF and symptoms: questions to ask in paediatric clinics. Eur Respir J. 1997; 24 (suppl): 80S-83S.
57. Bousquet, J.; Ndiaye, M.; Ait-Khaled, N.; Annesi-Maesano, I.; Vignola, A.M. Management of chronic respiratory and allergic diseases in developing countries. Focus on Sub-Saharan Africa. Allergy. 2003; 58: 265-283.
58. Rules of "2" s, trademark of Baylor College of Medicine.
59. Boychuck, R.B.., Kiyabu, K.M., DeMesa, C.J., Yamamoto, L.G. A simple algorithm to rapidly determine asthma severity classification in the emergency department. Abstract 22, AAAAI 61st. Annual meeting 2005.
60. th annual meeting. J Allergy Clin Imunol. 2004; S 116.
61. th annual meeting. J Allergy Clin Immunol. 2004; S 117.
62. Finkelstein, J., Joshi, A., Amelung. P. Evaluation of home tele-management in adult asthma patients. Abstract 250, AAAAAI 61st annual meeting 2005.
63. Indicadores de telefonia movil, CONATEL. Available from www.conatel.gov.ve, accesed June 2004.
64. Malka, S.; Capriles-Hulett, A.; Sanchez-Borges, M.; Perez-Lozano, A. International perspectives on controversial practices in allergic diseases: the South American experience. Clin Rev Allergy Immunol. 1996; 14: 271-287.